nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—Alitretinoin—hematologic cancer	0.212	1	CrCtD
Isotretinoin—Retinoids—Bexarotene—hematologic cancer	0.165	0.569	CiPCiCtD
Isotretinoin—Retinoids—Alitretinoin—hematologic cancer	0.125	0.431	CiPCiCtD
Isotretinoin—RARA—hematologic cancer	0.106	1	CbGaD
Isotretinoin—Vitamin A—Alitretinoin—hematologic cancer	0.0449	0.333	CrCrCtD
Isotretinoin—Tretinoin—Alitretinoin—hematologic cancer	0.0449	0.333	CrCrCtD
Isotretinoin—Acitretin—Alitretinoin—hematologic cancer	0.0449	0.333	CrCrCtD
Isotretinoin—RXRG—Bexarotene—hematologic cancer	0.0284	0.168	CbGbCtD
Isotretinoin—RXRA—Bexarotene—hematologic cancer	0.0251	0.149	CbGbCtD
Isotretinoin—RXRB—Bexarotene—hematologic cancer	0.0251	0.149	CbGbCtD
Isotretinoin—RARG—Alitretinoin—hematologic cancer	0.0163	0.0966	CbGbCtD
Isotretinoin—RXRG—Alitretinoin—hematologic cancer	0.0163	0.0966	CbGbCtD
Isotretinoin—RARA—Alitretinoin—hematologic cancer	0.0144	0.0854	CbGbCtD
Isotretinoin—RARB—Alitretinoin—hematologic cancer	0.0144	0.0854	CbGbCtD
Isotretinoin—RXRA—Alitretinoin—hematologic cancer	0.0144	0.0854	CbGbCtD
Isotretinoin—RXRB—Alitretinoin—hematologic cancer	0.0144	0.0854	CbGbCtD
Isotretinoin—RARG—hematopoietic system—hematologic cancer	0.00049	0.0941	CbGeAlD
Isotretinoin—RARA—hematopoietic system—hematologic cancer	0.000461	0.0884	CbGeAlD
Isotretinoin—RARA—gonad—hematologic cancer	0.00035	0.0672	CbGeAlD
Isotretinoin—RARB—lung—hematologic cancer	0.000349	0.067	CbGeAlD
Isotretinoin—RARG—blood—hematologic cancer	0.000325	0.0623	CbGeAlD
Isotretinoin—RXRG—testis—hematologic cancer	0.000322	0.0618	CbGeAlD
Isotretinoin—RXRB—lung—hematologic cancer	0.000321	0.0615	CbGeAlD
Isotretinoin—RARA—blood—hematologic cancer	0.000305	0.0586	CbGeAlD
Isotretinoin—RXRB—testis—hematologic cancer	0.000302	0.0581	CbGeAlD
Isotretinoin—RARA—bone marrow—hematologic cancer	0.000295	0.0567	CbGeAlD
Isotretinoin—RARG—lung—hematologic cancer	0.000285	0.0546	CbGeAlD
Isotretinoin—RARG—testis—hematologic cancer	0.000268	0.0516	CbGeAlD
Isotretinoin—RARA—lung—hematologic cancer	0.000268	0.0514	CbGeAlD
Isotretinoin—RARA—testis—hematologic cancer	0.000252	0.0485	CbGeAlD
Isotretinoin—Alitretinoin—CRABP1—hematologic cancer	0.000252	0.233	CrCbGaD
Isotretinoin—RARB—lymph node—hematologic cancer	0.000239	0.0458	CbGeAlD
Isotretinoin—Acitretin—RARA—hematologic cancer	0.000229	0.212	CrCbGaD
Isotretinoin—Alitretinoin—RARA—hematologic cancer	0.00022	0.203	CrCbGaD
Isotretinoin—RARG—lymph node—hematologic cancer	0.000195	0.0374	CbGeAlD
Isotretinoin—RARA—lymph node—hematologic cancer	0.000183	0.0351	CbGeAlD
Isotretinoin—Tretinoin—CRABP1—hematologic cancer	0.000177	0.164	CrCbGaD
Isotretinoin—Tretinoin—RARA—hematologic cancer	0.000155	0.143	CrCbGaD
Isotretinoin—Acitretin—ALB—hematologic cancer	2.48e-05	0.023	CrCbGaD
Isotretinoin—Alitretinoin—ABCB1—hematologic cancer	2.27e-05	0.021	CrCbGaD
Isotretinoin—RXRG—Gene Expression—EZH2—hematologic cancer	5.21e-06	0.000209	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—PARP1—hematologic cancer	5.19e-06	0.000209	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.15e-06	0.000207	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.13e-06	0.000206	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—CDKN1A—hematologic cancer	5.12e-06	0.000206	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.11e-06	0.000205	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—EZH2—hematologic cancer	5.11e-06	0.000205	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—H3F3A—hematologic cancer	5.11e-06	0.000205	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—H3F3A—hematologic cancer	5.11e-06	0.000205	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PARP1—hematologic cancer	5.1e-06	0.000205	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	5.09e-06	0.000204	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	5.02e-06	0.000202	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PTPRC—hematologic cancer	5.01e-06	0.000201	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—CREBBP—hematologic cancer	5.01e-06	0.000201	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—CREBBP—hematologic cancer	5.01e-06	0.000201	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.01e-06	0.000201	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PARP1—hematologic cancer	5e-06	0.000201	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—HDAC2—hematologic cancer	4.92e-06	0.000198	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.92e-06	0.000198	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—EZH2—hematologic cancer	4.9e-06	0.000197	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—EZH2—hematologic cancer	4.9e-06	0.000197	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	4.9e-06	0.000197	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—HDAC2—hematologic cancer	4.83e-06	0.000194	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CDA—hematologic cancer	4.8e-06	0.000193	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PARP1—hematologic cancer	4.8e-06	0.000193	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PARP1—hematologic cancer	4.8e-06	0.000193	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	4.78e-06	0.000192	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RARA—hematologic cancer	4.68e-06	0.000188	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—TET2—hematologic cancer	4.68e-06	0.000188	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AR—hematologic cancer	4.67e-06	0.000187	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—HDAC2—hematologic cancer	4.63e-06	0.000186	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—HDAC2—hematologic cancer	4.63e-06	0.000186	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PC—hematologic cancer	4.62e-06	0.000186	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RPLP1—hematologic cancer	4.59e-06	0.000184	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—STAT3—hematologic cancer	4.57e-06	0.000184	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	4.53e-06	0.000182	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	4.47e-06	0.00018	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GBA—hematologic cancer	4.46e-06	0.000179	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC35B2—hematologic cancer	4.46e-06	0.000179	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.46e-06	0.000179	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HSP90AA1—hematologic cancer	4.38e-06	0.000176	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NR0B2—hematologic cancer	4.35e-06	0.000175	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—AR—hematologic cancer	4.34e-06	0.000174	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.33e-06	0.000174	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—CDKN2B—hematologic cancer	4.3e-06	0.000173	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AR—hematologic cancer	4.27e-06	0.000171	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—TGFB1—hematologic cancer	4.24e-06	0.00017	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AR—hematologic cancer	4.18e-06	0.000168	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.15e-06	0.000167	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—DNMT3A—hematologic cancer	4.15e-06	0.000167	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ELL—hematologic cancer	4.09e-06	0.000164	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTAP—hematologic cancer	4.08e-06	0.000164	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	4.08e-06	0.000164	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NCOR1—hematologic cancer	4.08e-06	0.000164	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AR—hematologic cancer	4.01e-06	0.000161	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AR—hematologic cancer	4.01e-06	0.000161	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—CDKN2B—hematologic cancer	4e-06	0.000161	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	4e-06	0.000161	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—TNF—hematologic cancer	3.96e-06	0.000159	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—GRB2—hematologic cancer	3.95e-06	0.000159	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—CDKN2B—hematologic cancer	3.93e-06	0.000158	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NCOR2—hematologic cancer	3.93e-06	0.000158	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	3.89e-06	0.000156	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	3.88e-06	0.000156	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—TGFB1—hematologic cancer	3.86e-06	0.000155	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—CDKN2B—hematologic cancer	3.86e-06	0.000155	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ABL1—hematologic cancer	3.8e-06	0.000153	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NCOR1—hematologic cancer	3.8e-06	0.000153	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NR3C1—hematologic cancer	3.77e-06	0.000152	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	3.77e-06	0.000151	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—hematologic cancer	3.76e-06	0.000151	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	3.76e-06	0.000151	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.75e-06	0.000151	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NCOR1—hematologic cancer	3.73e-06	0.00015	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—CDKN2B—hematologic cancer	3.7e-06	0.000149	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—CDKN2B—hematologic cancer	3.7e-06	0.000149	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	3.68e-06	0.000148	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NCOR1—hematologic cancer	3.66e-06	0.000147	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—FHL2—hematologic cancer	3.64e-06	0.000146	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AGO2—hematologic cancer	3.62e-06	0.000146	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HES1—hematologic cancer	3.59e-06	0.000144	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	3.58e-06	0.000144	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NCOR1—hematologic cancer	3.57e-06	0.000144	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AGRN—hematologic cancer	3.57e-06	0.000143	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—H3F3B—hematologic cancer	3.55e-06	0.000143	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—DNMT3B—hematologic cancer	3.55e-06	0.000143	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NR3C1—hematologic cancer	3.51e-06	0.000141	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NCOR1—hematologic cancer	3.51e-06	0.000141	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NCOR1—hematologic cancer	3.51e-06	0.000141	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	3.48e-06	0.00014	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—FOXO1—hematologic cancer	3.48e-06	0.00014	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—hematologic cancer	3.46e-06	0.000139	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NR3C1—hematologic cancer	3.45e-06	0.000139	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—JAK1—hematologic cancer	3.41e-06	0.000137	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.39e-06	0.000136	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NR3C1—hematologic cancer	3.38e-06	0.000136	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HMMR—hematologic cancer	3.38e-06	0.000136	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—IDH2—hematologic cancer	3.38e-06	0.000136	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MAPK14—hematologic cancer	3.27e-06	0.000131	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NR3C1—hematologic cancer	3.24e-06	0.00013	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NR3C1—hematologic cancer	3.24e-06	0.00013	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RPS14—hematologic cancer	3.24e-06	0.00013	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	3.21e-06	0.000129	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—ESR1—hematologic cancer	3.2e-06	0.000129	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NUP98—hematologic cancer	3.19e-06	0.000128	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IL6—hematologic cancer	3.19e-06	0.000128	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.19e-06	0.000128	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ARNTL—hematologic cancer	3.18e-06	0.000128	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—hematologic cancer	3.17e-06	0.000127	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.13e-06	0.000126	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	3.12e-06	0.000125	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	3.11e-06	0.000125	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—hematologic cancer	3.1e-06	0.000125	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NOTCH1—hematologic cancer	3.1e-06	0.000124	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ACP5—hematologic cancer	3.09e-06	0.000124	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CA9—hematologic cancer	3.09e-06	0.000124	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NUP214—hematologic cancer	3.08e-06	0.000124	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOR2—hematologic cancer	3.05e-06	0.000123	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MAPK14—hematologic cancer	2.99e-06	0.00012	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR1—hematologic cancer	2.98e-06	0.00012	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—hematologic cancer	2.98e-06	0.00012	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—hematologic cancer	2.98e-06	0.00012	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ESR1—hematologic cancer	2.93e-06	0.000118	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MAPK14—hematologic cancer	2.93e-06	0.000118	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—IDH1—hematologic cancer	2.91e-06	0.000117	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.91e-06	0.000117	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.88e-06	0.000116	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NOTCH1—hematologic cancer	2.88e-06	0.000116	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TXN—hematologic cancer	2.88e-06	0.000116	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCC3—hematologic cancer	2.88e-06	0.000116	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTO1—hematologic cancer	2.88e-06	0.000116	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ESR1—hematologic cancer	2.87e-06	0.000115	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MAPK14—hematologic cancer	2.86e-06	0.000115	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EIF4EBP1—hematologic cancer	2.84e-06	0.000114	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HSPB1—hematologic cancer	2.84e-06	0.000114	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NOTCH1—hematologic cancer	2.83e-06	0.000114	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MET—hematologic cancer	2.82e-06	0.000113	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CDK4—hematologic cancer	2.82e-06	0.000113	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SPHK1—hematologic cancer	2.82e-06	0.000113	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MAPK14—hematologic cancer	2.81e-06	0.000113	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MAPK14—hematologic cancer	2.81e-06	0.000113	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—CREBBP—hematologic cancer	2.81e-06	0.000113	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NOTCH1—hematologic cancer	2.78e-06	0.000112	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ESR1—hematologic cancer	2.75e-06	0.000111	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ESR1—hematologic cancer	2.75e-06	0.000111	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SMC1A—hematologic cancer	2.72e-06	0.000109	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NOTCH1—hematologic cancer	2.71e-06	0.000109	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—UGT1A1—hematologic cancer	2.71e-06	0.000109	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NOTCH1—hematologic cancer	2.66e-06	0.000107	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NOTCH1—hematologic cancer	2.66e-06	0.000107	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—H3F3A—hematologic cancer	2.66e-06	0.000107	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.65e-06	0.000106	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC22A1—hematologic cancer	2.63e-06	0.000106	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CRABP1—hematologic cancer	2.63e-06	0.000106	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—CREBBP—hematologic cancer	2.61e-06	0.000105	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PTPN11—hematologic cancer	2.61e-06	0.000105	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—CREBBP—hematologic cancer	2.57e-06	0.000103	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALOX5—hematologic cancer	2.56e-06	0.000103	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.56e-06	0.000103	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EZH2—hematologic cancer	2.55e-06	0.000103	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CREB1—hematologic cancer	2.53e-06	0.000101	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—CREBBP—hematologic cancer	2.52e-06	0.000101	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PARP1—hematologic cancer	2.5e-06	0.0001	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NUP98—hematologic cancer	2.48e-06	9.98e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6R—hematologic cancer	2.46e-06	9.9e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CREBBP—hematologic cancer	2.46e-06	9.88e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—CREBBP—hematologic cancer	2.41e-06	9.7e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—CREBBP—hematologic cancer	2.41e-06	9.7e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HDAC2—hematologic cancer	2.41e-06	9.69e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ADCY7—hematologic cancer	2.41e-06	9.69e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOA3—hematologic cancer	2.41e-06	9.69e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NUP214—hematologic cancer	2.39e-06	9.62e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.37e-06	9.52e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MAP2K1—hematologic cancer	2.35e-06	9.43e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCG2—hematologic cancer	2.35e-06	9.42e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTR—hematologic cancer	2.35e-06	9.42e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ENO2—hematologic cancer	2.3e-06	9.24e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—FGF2—hematologic cancer	2.23e-06	8.97e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTT1—hematologic cancer	2.23e-06	8.96e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.2e-06	8.83e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SDC1—hematologic cancer	2.18e-06	8.76e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.17e-06	8.7e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—JAK2—hematologic cancer	2.14e-06	8.6e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AR—hematologic cancer	2.09e-06	8.4e-05	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.09e-06	8.39e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.08e-06	8.37e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.06e-06	8.26e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.97e-06	7.9e-05	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ALB—hematologic cancer	1.96e-06	7.86e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—CDKN2B—hematologic cancer	1.93e-06	7.74e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NQO1—hematologic cancer	1.85e-06	7.45e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CD44—hematologic cancer	1.85e-06	7.45e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NCOR1—hematologic cancer	1.83e-06	7.34e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.82e-06	7.29e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYCS—hematologic cancer	1.75e-06	7.05e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HSP90AA1—hematologic cancer	1.74e-06	7e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MAPK3—hematologic cancer	1.71e-06	6.88e-05	CbGpPWpGaD
Isotretinoin—Dermatitis—Cisplatin—hematologic cancer	1.71e-06	2.99e-05	CcSEcCtD
Isotretinoin—Malnutrition—Epirubicin—hematologic cancer	1.71e-06	2.98e-05	CcSEcCtD
Isotretinoin—Erythema—Epirubicin—hematologic cancer	1.71e-06	2.98e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Etoposide—hematologic cancer	1.7e-06	2.97e-05	CcSEcCtD
Isotretinoin—Anorexia—Prednisone—hematologic cancer	1.7e-06	2.97e-05	CcSEcCtD
Isotretinoin—Eye disorder—Doxorubicin—hematologic cancer	1.7e-06	2.96e-05	CcSEcCtD
Isotretinoin—Ill-defined disorder—Methotrexate—hematologic cancer	1.7e-06	2.96e-05	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—hematologic cancer	1.7e-06	2.96e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—NR3C1—hematologic cancer	1.69e-06	6.79e-05	CbGpPWpGaD
Isotretinoin—Anaemia—Methotrexate—hematologic cancer	1.69e-06	2.95e-05	CcSEcCtD
Isotretinoin—Feeling abnormal—Dexamethasone—hematologic cancer	1.69e-06	2.95e-05	CcSEcCtD
Isotretinoin—Feeling abnormal—Betamethasone—hematologic cancer	1.69e-06	2.95e-05	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—hematologic cancer	1.69e-06	2.94e-05	CcSEcCtD
Isotretinoin—Flatulence—Epirubicin—hematologic cancer	1.69e-06	2.94e-05	CcSEcCtD
Isotretinoin—Tension—Epirubicin—hematologic cancer	1.68e-06	2.93e-05	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.68e-06	2.92e-05	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.68e-06	2.92e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—EP300—hematologic cancer	1.68e-06	6.73e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—hematologic cancer	1.67e-06	6.69e-05	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Triamcinolone—hematologic cancer	1.66e-06	2.9e-05	CcSEcCtD
Isotretinoin—Nervousness—Epirubicin—hematologic cancer	1.66e-06	2.9e-05	CcSEcCtD
Isotretinoin—Back pain—Epirubicin—hematologic cancer	1.65e-06	2.89e-05	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—hematologic cancer	1.65e-06	2.88e-05	CcSEcCtD
Isotretinoin—Malaise—Methotrexate—hematologic cancer	1.65e-06	2.87e-05	CcSEcCtD
Isotretinoin—Dizziness—Etoposide—hematologic cancer	1.65e-06	2.87e-05	CcSEcCtD
Isotretinoin—Chills—Doxorubicin—hematologic cancer	1.63e-06	2.85e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—SRC—hematologic cancer	1.63e-06	6.55e-05	CbGpPWpGaD
Isotretinoin—Urticaria—Dexamethasone—hematologic cancer	1.63e-06	2.84e-05	CcSEcCtD
Isotretinoin—Urticaria—Betamethasone—hematologic cancer	1.63e-06	2.84e-05	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.63e-06	2.84e-05	CcSEcCtD
Isotretinoin—Dizziness—Prednisolone—hematologic cancer	1.62e-06	2.83e-05	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—hematologic cancer	1.62e-06	2.83e-05	CcSEcCtD
Isotretinoin—Asthenia—Triamcinolone—hematologic cancer	1.62e-06	2.83e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Dexamethasone—hematologic cancer	1.62e-06	2.83e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Betamethasone—hematologic cancer	1.62e-06	2.83e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Dexamethasone—hematologic cancer	1.62e-06	2.83e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Betamethasone—hematologic cancer	1.62e-06	2.83e-05	CcSEcCtD
Isotretinoin—Nausea—Cisplatin—hematologic cancer	1.61e-06	2.82e-05	CcSEcCtD
Isotretinoin—Insomnia—Prednisone—hematologic cancer	1.61e-06	2.82e-05	CcSEcCtD
Isotretinoin—Vision blurred—Epirubicin—hematologic cancer	1.61e-06	2.81e-05	CcSEcCtD
Isotretinoin—Alopecia—Doxorubicin—hematologic cancer	1.61e-06	2.8e-05	CcSEcCtD
Isotretinoin—Paraesthesia—Prednisone—hematologic cancer	1.6e-06	2.8e-05	CcSEcCtD
Isotretinoin—Pruritus—Triamcinolone—hematologic cancer	1.6e-06	2.79e-05	CcSEcCtD
Isotretinoin—Cough—Methotrexate—hematologic cancer	1.59e-06	2.78e-05	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—hematologic cancer	1.59e-06	2.78e-05	CcSEcCtD
Isotretinoin—Ill-defined disorder—Epirubicin—hematologic cancer	1.59e-06	2.77e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—VEGFA—hematologic cancer	1.59e-06	6.38e-05	CbGpPWpGaD
Isotretinoin—Convulsion—Methotrexate—hematologic cancer	1.58e-06	2.76e-05	CcSEcCtD
Isotretinoin—Vomiting—Etoposide—hematologic cancer	1.58e-06	2.76e-05	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—hematologic cancer	1.58e-06	2.76e-05	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—hematologic cancer	1.58e-06	2.76e-05	CcSEcCtD
Isotretinoin—Anaemia—Epirubicin—hematologic cancer	1.58e-06	2.76e-05	CcSEcCtD
Isotretinoin—Agitation—Epirubicin—hematologic cancer	1.57e-06	2.74e-05	CcSEcCtD
Isotretinoin—Dyspepsia—Prednisone—hematologic cancer	1.57e-06	2.74e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—STAT3—hematologic cancer	1.57e-06	6.31e-05	CbGpPWpGaD
Isotretinoin—Rash—Etoposide—hematologic cancer	1.57e-06	2.74e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.57e-06	6.3e-05	CbGpPWpGaD
Isotretinoin—Dermatitis—Etoposide—hematologic cancer	1.57e-06	2.74e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—NRAS—hematologic cancer	1.57e-06	6.3e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MAPK3—hematologic cancer	1.57e-06	6.3e-05	CbGpPWpGaD
Isotretinoin—Headache—Etoposide—hematologic cancer	1.56e-06	2.72e-05	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—hematologic cancer	1.56e-06	2.72e-05	CcSEcCtD
Isotretinoin—Myalgia—Methotrexate—hematologic cancer	1.56e-06	2.71e-05	CcSEcCtD
Isotretinoin—Chest pain—Methotrexate—hematologic cancer	1.56e-06	2.71e-05	CcSEcCtD
Isotretinoin—Arthralgia—Methotrexate—hematologic cancer	1.56e-06	2.71e-05	CcSEcCtD
Isotretinoin—Tension—Doxorubicin—hematologic cancer	1.55e-06	2.71e-05	CcSEcCtD
Isotretinoin—Decreased appetite—Prednisone—hematologic cancer	1.55e-06	2.71e-05	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—hematologic cancer	1.55e-06	6.23e-05	CbGpPWpGaD
Isotretinoin—Rash—Prednisolone—hematologic cancer	1.55e-06	2.7e-05	CcSEcCtD
Isotretinoin—Dermatitis—Prednisolone—hematologic cancer	1.55e-06	2.7e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GSTP1—hematologic cancer	1.55e-06	6.21e-05	CbGpPWpGaD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.55e-06	2.7e-05	CcSEcCtD
Isotretinoin—Malaise—Epirubicin—hematologic cancer	1.54e-06	2.69e-05	CcSEcCtD
Isotretinoin—Fatigue—Prednisone—hematologic cancer	1.54e-06	2.68e-05	CcSEcCtD
Isotretinoin—Headache—Prednisolone—hematologic cancer	1.54e-06	2.68e-05	CcSEcCtD
Isotretinoin—Discomfort—Methotrexate—hematologic cancer	1.54e-06	2.68e-05	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—hematologic cancer	1.54e-06	2.68e-05	CcSEcCtD
Isotretinoin—RARB—Gene Expression—MAPK3—hematologic cancer	1.54e-06	6.17e-05	CbGpPWpGaD
Isotretinoin—Syncope—Epirubicin—hematologic cancer	1.53e-06	2.68e-05	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—hematologic cancer	1.53e-06	2.67e-05	CcSEcCtD
Isotretinoin—Constipation—Prednisone—hematologic cancer	1.53e-06	2.66e-05	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—MYC—hematologic cancer	1.52e-06	6.12e-05	CbGpPWpGaD
Isotretinoin—Palpitations—Epirubicin—hematologic cancer	1.51e-06	2.64e-05	CcSEcCtD
Isotretinoin—Confusional state—Methotrexate—hematologic cancer	1.5e-06	2.62e-05	CcSEcCtD
Isotretinoin—Loss of consciousness—Epirubicin—hematologic cancer	1.5e-06	2.62e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MAPK3—hematologic cancer	1.5e-06	6.03e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.5e-06	6.01e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MYC—hematologic cancer	1.49e-06	6e-05	CbGpPWpGaD
Isotretinoin—Dizziness—Triamcinolone—hematologic cancer	1.49e-06	2.61e-05	CcSEcCtD
Isotretinoin—Cough—Epirubicin—hematologic cancer	1.49e-06	2.6e-05	CcSEcCtD
Isotretinoin—Anaphylactic shock—Methotrexate—hematologic cancer	1.49e-06	2.6e-05	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—hematologic cancer	1.49e-06	2.6e-05	CcSEcCtD
Isotretinoin—Convulsion—Epirubicin—hematologic cancer	1.48e-06	2.58e-05	CcSEcCtD
Isotretinoin—Infection—Methotrexate—hematologic cancer	1.48e-06	2.58e-05	CcSEcCtD
Isotretinoin—Nausea—Etoposide—hematologic cancer	1.48e-06	2.58e-05	CcSEcCtD
Isotretinoin—Hypertension—Epirubicin—hematologic cancer	1.48e-06	2.58e-05	CcSEcCtD
Isotretinoin—RARA—Gene Expression—MAPK3—hematologic cancer	1.47e-06	5.92e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MAPK3—hematologic cancer	1.47e-06	5.92e-05	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Prednisone—hematologic cancer	1.47e-06	2.57e-05	CcSEcCtD
Isotretinoin—Asthenia—Betamethasone—hematologic cancer	1.47e-06	2.56e-05	CcSEcCtD
Isotretinoin—Asthenia—Dexamethasone—hematologic cancer	1.47e-06	2.56e-05	CcSEcCtD
Isotretinoin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.47e-06	2.56e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ABCB1—hematologic cancer	1.46e-06	5.88e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MAPK14—hematologic cancer	1.46e-06	5.88e-05	CbGpPWpGaD
Isotretinoin—Nervous system disorder—Methotrexate—hematologic cancer	1.46e-06	2.55e-05	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—hematologic cancer	1.46e-06	2.55e-05	CcSEcCtD
Isotretinoin—Thrombocytopenia—Methotrexate—hematologic cancer	1.46e-06	2.55e-05	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Prednisone—hematologic cancer	1.46e-06	2.55e-05	CcSEcCtD
Isotretinoin—Nausea—Prednisolone—hematologic cancer	1.46e-06	2.54e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—TGFB1—hematologic cancer	1.46e-06	5.85e-05	CbGpPWpGaD
Isotretinoin—Myalgia—Epirubicin—hematologic cancer	1.46e-06	2.54e-05	CcSEcCtD
Isotretinoin—Arthralgia—Epirubicin—hematologic cancer	1.46e-06	2.54e-05	CcSEcCtD
Isotretinoin—Chest pain—Epirubicin—hematologic cancer	1.46e-06	2.54e-05	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—hematologic cancer	1.45e-06	2.54e-05	CcSEcCtD
Isotretinoin—Anxiety—Epirubicin—hematologic cancer	1.45e-06	2.53e-05	CcSEcCtD
Isotretinoin—Pruritus—Betamethasone—hematologic cancer	1.45e-06	2.53e-05	CcSEcCtD
Isotretinoin—Pruritus—Dexamethasone—hematologic cancer	1.45e-06	2.53e-05	CcSEcCtD
Isotretinoin—Skin disorder—Methotrexate—hematologic cancer	1.45e-06	2.53e-05	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.45e-06	2.52e-05	CcSEcCtD
Isotretinoin—Hyperhidrosis—Methotrexate—hematologic cancer	1.44e-06	2.52e-05	CcSEcCtD
Isotretinoin—Discomfort—Epirubicin—hematologic cancer	1.44e-06	2.51e-05	CcSEcCtD
Isotretinoin—Vomiting—Triamcinolone—hematologic cancer	1.44e-06	2.5e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—ESR1—hematologic cancer	1.44e-06	5.77e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—hematologic cancer	1.43e-06	5.76e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—hematologic cancer	1.43e-06	5.76e-05	CbGpPWpGaD
Isotretinoin—Malaise—Doxorubicin—hematologic cancer	1.43e-06	2.49e-05	CcSEcCtD
Isotretinoin—Rash—Triamcinolone—hematologic cancer	1.42e-06	2.48e-05	CcSEcCtD
Isotretinoin—Dry mouth—Epirubicin—hematologic cancer	1.42e-06	2.48e-05	CcSEcCtD
Isotretinoin—Dermatitis—Triamcinolone—hematologic cancer	1.42e-06	2.48e-05	CcSEcCtD
Isotretinoin—Anorexia—Methotrexate—hematologic cancer	1.42e-06	2.48e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—NCOR1—hematologic cancer	1.42e-06	5.71e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTM1—hematologic cancer	1.42e-06	5.71e-05	CbGpPWpGaD
Isotretinoin—Syncope—Doxorubicin—hematologic cancer	1.42e-06	2.48e-05	CcSEcCtD
Isotretinoin—Urticaria—Prednisone—hematologic cancer	1.42e-06	2.47e-05	CcSEcCtD
Isotretinoin—Headache—Triamcinolone—hematologic cancer	1.42e-06	2.47e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Prednisone—hematologic cancer	1.41e-06	2.46e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Prednisone—hematologic cancer	1.41e-06	2.46e-05	CcSEcCtD
Isotretinoin—Confusional state—Epirubicin—hematologic cancer	1.41e-06	2.45e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Betamethasone—hematologic cancer	1.4e-06	2.45e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Dexamethasone—hematologic cancer	1.4e-06	2.45e-05	CcSEcCtD
Isotretinoin—Palpitations—Doxorubicin—hematologic cancer	1.4e-06	2.44e-05	CcSEcCtD
Isotretinoin—Anaphylactic shock—Epirubicin—hematologic cancer	1.4e-06	2.43e-05	CcSEcCtD
Isotretinoin—Oedema—Epirubicin—hematologic cancer	1.4e-06	2.43e-05	CcSEcCtD
Isotretinoin—Hypotension—Methotrexate—hematologic cancer	1.39e-06	2.43e-05	CcSEcCtD
Isotretinoin—Loss of consciousness—Doxorubicin—hematologic cancer	1.39e-06	2.43e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—NOTCH1—hematologic cancer	1.39e-06	5.58e-05	CbGpPWpGaD
Isotretinoin—Infection—Epirubicin—hematologic cancer	1.39e-06	2.42e-05	CcSEcCtD
Isotretinoin—Cough—Doxorubicin—hematologic cancer	1.38e-06	2.41e-05	CcSEcCtD
Isotretinoin—Shock—Epirubicin—hematologic cancer	1.37e-06	2.4e-05	CcSEcCtD
Isotretinoin—Convulsion—Doxorubicin—hematologic cancer	1.37e-06	2.39e-05	CcSEcCtD
Isotretinoin—Nervous system disorder—Epirubicin—hematologic cancer	1.37e-06	2.39e-05	CcSEcCtD
Isotretinoin—Thrombocytopenia—Epirubicin—hematologic cancer	1.37e-06	2.38e-05	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—hematologic cancer	1.37e-06	2.38e-05	CcSEcCtD
Isotretinoin—Tachycardia—Epirubicin—hematologic cancer	1.36e-06	2.38e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—TNF—hematologic cancer	1.36e-06	5.46e-05	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.36e-06	2.37e-05	CcSEcCtD
Isotretinoin—Skin disorder—Epirubicin—hematologic cancer	1.36e-06	2.36e-05	CcSEcCtD
Isotretinoin—Dizziness—Betamethasone—hematologic cancer	1.36e-06	2.36e-05	CcSEcCtD
Isotretinoin—Dizziness—Dexamethasone—hematologic cancer	1.36e-06	2.36e-05	CcSEcCtD
Isotretinoin—Hyperhidrosis—Epirubicin—hematologic cancer	1.35e-06	2.35e-05	CcSEcCtD
Isotretinoin—Insomnia—Methotrexate—hematologic cancer	1.35e-06	2.35e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—KRAS—hematologic cancer	1.35e-06	5.42e-05	CbGpPWpGaD
Isotretinoin—Myalgia—Doxorubicin—hematologic cancer	1.35e-06	2.35e-05	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—hematologic cancer	1.35e-06	2.35e-05	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—hematologic cancer	1.35e-06	2.35e-05	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—hematologic cancer	1.34e-06	2.34e-05	CcSEcCtD
Isotretinoin—Nausea—Triamcinolone—hematologic cancer	1.34e-06	2.34e-05	CcSEcCtD
Isotretinoin—Paraesthesia—Methotrexate—hematologic cancer	1.34e-06	2.34e-05	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.34e-06	2.33e-05	CcSEcCtD
Isotretinoin—Discomfort—Doxorubicin—hematologic cancer	1.33e-06	2.32e-05	CcSEcCtD
Isotretinoin—Anorexia—Epirubicin—hematologic cancer	1.33e-06	2.32e-05	CcSEcCtD
Isotretinoin—Dyspnoea—Methotrexate—hematologic cancer	1.33e-06	2.32e-05	CcSEcCtD
Isotretinoin—Somnolence—Methotrexate—hematologic cancer	1.33e-06	2.31e-05	CcSEcCtD
Isotretinoin—Dry mouth—Doxorubicin—hematologic cancer	1.32e-06	2.3e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Prednisone—hematologic cancer	1.32e-06	2.29e-05	CcSEcCtD
Isotretinoin—Dyspepsia—Methotrexate—hematologic cancer	1.31e-06	2.29e-05	CcSEcCtD
Isotretinoin—Hypotension—Epirubicin—hematologic cancer	1.3e-06	2.28e-05	CcSEcCtD
Isotretinoin—Vomiting—Dexamethasone—hematologic cancer	1.3e-06	2.27e-05	CcSEcCtD
Isotretinoin—Vomiting—Betamethasone—hematologic cancer	1.3e-06	2.27e-05	CcSEcCtD
Isotretinoin—Confusional state—Doxorubicin—hematologic cancer	1.3e-06	2.27e-05	CcSEcCtD
Isotretinoin—Decreased appetite—Methotrexate—hematologic cancer	1.3e-06	2.26e-05	CcSEcCtD
Isotretinoin—Rash—Betamethasone—hematologic cancer	1.29e-06	2.25e-05	CcSEcCtD
Isotretinoin—Rash—Dexamethasone—hematologic cancer	1.29e-06	2.25e-05	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.29e-06	2.25e-05	CcSEcCtD
Isotretinoin—Oedema—Doxorubicin—hematologic cancer	1.29e-06	2.25e-05	CcSEcCtD
Isotretinoin—Dermatitis—Betamethasone—hematologic cancer	1.29e-06	2.25e-05	CcSEcCtD
Isotretinoin—Dermatitis—Dexamethasone—hematologic cancer	1.29e-06	2.25e-05	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.29e-06	2.25e-05	CcSEcCtD
Isotretinoin—Fatigue—Methotrexate—hematologic cancer	1.29e-06	2.24e-05	CcSEcCtD
Isotretinoin—Headache—Dexamethasone—hematologic cancer	1.28e-06	2.24e-05	CcSEcCtD
Isotretinoin—Headache—Betamethasone—hematologic cancer	1.28e-06	2.24e-05	CcSEcCtD
Isotretinoin—Infection—Doxorubicin—hematologic cancer	1.28e-06	2.24e-05	CcSEcCtD
Isotretinoin—Asthenia—Prednisone—hematologic cancer	1.28e-06	2.23e-05	CcSEcCtD
Isotretinoin—Pain—Methotrexate—hematologic cancer	1.28e-06	2.22e-05	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.27e-06	2.22e-05	CcSEcCtD
Isotretinoin—Shock—Doxorubicin—hematologic cancer	1.27e-06	2.22e-05	CcSEcCtD
Isotretinoin—Nervous system disorder—Doxorubicin—hematologic cancer	1.27e-06	2.21e-05	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.26e-06	2.21e-05	CcSEcCtD
Isotretinoin—Pruritus—Prednisone—hematologic cancer	1.26e-06	2.2e-05	CcSEcCtD
Isotretinoin—Insomnia—Epirubicin—hematologic cancer	1.26e-06	2.2e-05	CcSEcCtD
Isotretinoin—Tachycardia—Doxorubicin—hematologic cancer	1.26e-06	2.2e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—CREBBP—hematologic cancer	1.26e-06	5.06e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTHFR—hematologic cancer	1.26e-06	5.05e-05	CbGpPWpGaD
Isotretinoin—Skin disorder—Doxorubicin—hematologic cancer	1.25e-06	2.19e-05	CcSEcCtD
Isotretinoin—Paraesthesia—Epirubicin—hematologic cancer	1.25e-06	2.19e-05	CcSEcCtD
Isotretinoin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.25e-06	2.18e-05	CcSEcCtD
Isotretinoin—Dyspnoea—Epirubicin—hematologic cancer	1.24e-06	2.17e-05	CcSEcCtD
Isotretinoin—Somnolence—Epirubicin—hematologic cancer	1.24e-06	2.16e-05	CcSEcCtD
Isotretinoin—Anorexia—Doxorubicin—hematologic cancer	1.23e-06	2.15e-05	CcSEcCtD
Isotretinoin—Feeling abnormal—Methotrexate—hematologic cancer	1.23e-06	2.14e-05	CcSEcCtD
Isotretinoin—Dyspepsia—Epirubicin—hematologic cancer	1.23e-06	2.14e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Prednisone—hematologic cancer	1.22e-06	2.13e-05	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.22e-06	2.13e-05	CcSEcCtD
Isotretinoin—Nausea—Betamethasone—hematologic cancer	1.22e-06	2.12e-05	CcSEcCtD
Isotretinoin—Nausea—Dexamethasone—hematologic cancer	1.22e-06	2.12e-05	CcSEcCtD
Isotretinoin—Decreased appetite—Epirubicin—hematologic cancer	1.21e-06	2.12e-05	CcSEcCtD
Isotretinoin—Hypotension—Doxorubicin—hematologic cancer	1.21e-06	2.11e-05	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.21e-06	2.1e-05	CcSEcCtD
Isotretinoin—Fatigue—Epirubicin—hematologic cancer	1.2e-06	2.1e-05	CcSEcCtD
Isotretinoin—Pain—Epirubicin—hematologic cancer	1.19e-06	2.08e-05	CcSEcCtD
Isotretinoin—Constipation—Epirubicin—hematologic cancer	1.19e-06	2.08e-05	CcSEcCtD
Isotretinoin—Urticaria—Methotrexate—hematologic cancer	1.19e-06	2.07e-05	CcSEcCtD
Isotretinoin—Dizziness—Prednisone—hematologic cancer	1.18e-06	2.06e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Methotrexate—hematologic cancer	1.18e-06	2.06e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Methotrexate—hematologic cancer	1.18e-06	2.06e-05	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.18e-06	2.05e-05	CcSEcCtD
Isotretinoin—Insomnia—Doxorubicin—hematologic cancer	1.17e-06	2.04e-05	CcSEcCtD
Isotretinoin—Paraesthesia—Doxorubicin—hematologic cancer	1.16e-06	2.02e-05	CcSEcCtD
Isotretinoin—RARG—Gene Expression—AKT1—hematologic cancer	1.16e-06	4.64e-05	CbGpPWpGaD
Isotretinoin—Dyspnoea—Doxorubicin—hematologic cancer	1.15e-06	2.01e-05	CcSEcCtD
Isotretinoin—Feeling abnormal—Epirubicin—hematologic cancer	1.15e-06	2.01e-05	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—hematologic cancer	1.15e-06	2e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—HRAS—hematologic cancer	1.15e-06	4.61e-05	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.14e-06	1.99e-05	CcSEcCtD
Isotretinoin—Dyspepsia—Doxorubicin—hematologic cancer	1.14e-06	1.98e-05	CcSEcCtD
Isotretinoin—Vomiting—Prednisone—hematologic cancer	1.13e-06	1.98e-05	CcSEcCtD
Isotretinoin—Rash—Prednisone—hematologic cancer	1.13e-06	1.96e-05	CcSEcCtD
Isotretinoin—Dermatitis—Prednisone—hematologic cancer	1.12e-06	1.96e-05	CcSEcCtD
Isotretinoin—Decreased appetite—Doxorubicin—hematologic cancer	1.12e-06	1.96e-05	CcSEcCtD
Isotretinoin—Headache—Prednisone—hematologic cancer	1.12e-06	1.95e-05	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.12e-06	1.94e-05	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—hematologic cancer	1.11e-06	1.94e-05	CcSEcCtD
Isotretinoin—Urticaria—Epirubicin—hematologic cancer	1.11e-06	1.93e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.11e-06	4.45e-05	CbGpPWpGaD
Isotretinoin—Constipation—Doxorubicin—hematologic cancer	1.1e-06	1.93e-05	CcSEcCtD
Isotretinoin—Pain—Doxorubicin—hematologic cancer	1.1e-06	1.93e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Epirubicin—hematologic cancer	1.1e-06	1.92e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Epirubicin—hematologic cancer	1.1e-06	1.92e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Methotrexate—hematologic cancer	1.1e-06	1.92e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—IL6—hematologic cancer	1.1e-06	4.41e-05	CbGpPWpGaD
Isotretinoin—Asthenia—Methotrexate—hematologic cancer	1.07e-06	1.87e-05	CcSEcCtD
Isotretinoin—Feeling abnormal—Doxorubicin—hematologic cancer	1.06e-06	1.86e-05	CcSEcCtD
Isotretinoin—Nausea—Prednisone—hematologic cancer	1.06e-06	1.85e-05	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—AKT1—hematologic cancer	1.06e-06	4.25e-05	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.06e-06	1.84e-05	CcSEcCtD
Isotretinoin—Pruritus—Methotrexate—hematologic cancer	1.06e-06	1.84e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—PIK3CG—hematologic cancer	1.06e-06	4.24e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AKT1—hematologic cancer	1.04e-06	4.16e-05	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Epirubicin—hematologic cancer	1.03e-06	1.79e-05	CcSEcCtD
Isotretinoin—Urticaria—Doxorubicin—hematologic cancer	1.03e-06	1.79e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—hematologic cancer	1.02e-06	1.78e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—hematologic cancer	1.02e-06	1.78e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Methotrexate—hematologic cancer	1.02e-06	1.78e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—AKT1—hematologic cancer	1.01e-06	4.07e-05	CbGpPWpGaD
Isotretinoin—Asthenia—Epirubicin—hematologic cancer	1e-06	1.75e-05	CcSEcCtD
Isotretinoin—RARA—Gene Expression—AKT1—hematologic cancer	9.94e-07	3.99e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AKT1—hematologic cancer	9.94e-07	3.99e-05	CbGpPWpGaD
Isotretinoin—Pruritus—Epirubicin—hematologic cancer	9.88e-07	1.72e-05	CcSEcCtD
Isotretinoin—Dizziness—Methotrexate—hematologic cancer	9.86e-07	1.72e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CREBBP—hematologic cancer	9.78e-07	3.93e-05	CbGpPWpGaD
Isotretinoin—Diarrhoea—Epirubicin—hematologic cancer	9.55e-07	1.67e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Doxorubicin—hematologic cancer	9.52e-07	1.66e-05	CcSEcCtD
Isotretinoin—Vomiting—Methotrexate—hematologic cancer	9.48e-07	1.65e-05	CcSEcCtD
Isotretinoin—Rash—Methotrexate—hematologic cancer	9.41e-07	1.64e-05	CcSEcCtD
Isotretinoin—Dermatitis—Methotrexate—hematologic cancer	9.4e-07	1.64e-05	CcSEcCtD
Isotretinoin—Headache—Methotrexate—hematologic cancer	9.34e-07	1.63e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—PIK3CD—hematologic cancer	9.28e-07	3.73e-05	CbGpPWpGaD
Isotretinoin—Asthenia—Doxorubicin—hematologic cancer	9.27e-07	1.62e-05	CcSEcCtD
Isotretinoin—Dizziness—Epirubicin—hematologic cancer	9.23e-07	1.61e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ALB—hematologic cancer	9.16e-07	3.68e-05	CbGpPWpGaD
Isotretinoin—Pruritus—Doxorubicin—hematologic cancer	9.14e-07	1.59e-05	CcSEcCtD
Isotretinoin—Vomiting—Epirubicin—hematologic cancer	8.88e-07	1.55e-05	CcSEcCtD
Isotretinoin—Nausea—Methotrexate—hematologic cancer	8.86e-07	1.55e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Doxorubicin—hematologic cancer	8.84e-07	1.54e-05	CcSEcCtD
Isotretinoin—Rash—Epirubicin—hematologic cancer	8.8e-07	1.54e-05	CcSEcCtD
Isotretinoin—Dermatitis—Epirubicin—hematologic cancer	8.79e-07	1.53e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—PIK3R1—hematologic cancer	8.76e-07	3.52e-05	CbGpPWpGaD
Isotretinoin—Headache—Epirubicin—hematologic cancer	8.75e-07	1.53e-05	CcSEcCtD
Isotretinoin—Dizziness—Doxorubicin—hematologic cancer	8.54e-07	1.49e-05	CcSEcCtD
Isotretinoin—Nausea—Epirubicin—hematologic cancer	8.29e-07	1.45e-05	CcSEcCtD
Isotretinoin—Vomiting—Doxorubicin—hematologic cancer	8.21e-07	1.43e-05	CcSEcCtD
Isotretinoin—Rash—Doxorubicin—hematologic cancer	8.14e-07	1.42e-05	CcSEcCtD
Isotretinoin—Dermatitis—Doxorubicin—hematologic cancer	8.14e-07	1.42e-05	CcSEcCtD
Isotretinoin—Headache—Doxorubicin—hematologic cancer	8.09e-07	1.41e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—PIK3CB—hematologic cancer	8.09e-07	3.25e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MAPK3—hematologic cancer	7.68e-07	3.08e-05	CbGpPWpGaD
Isotretinoin—Nausea—Doxorubicin—hematologic cancer	7.67e-07	1.34e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—MYC—hematologic cancer	7.47e-07	3e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTEN—hematologic cancer	6.99e-07	2.81e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—EP300—hematologic cancer	6.66e-07	2.68e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AKT1—hematologic cancer	5.18e-07	2.08e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CA—hematologic cancer	4.93e-07	1.98e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKT1—hematologic cancer	4.03e-07	1.62e-05	CbGpPWpGaD
